{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:50:40Z","timestamp":1782377440234,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cbi.2026.112135","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:08:47Z","timestamp":1778339327000},"page":"112135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Saroglitazar, a novel PPAR-\u03b1\/\u03b3 agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats"],"prefix":"10.1016","volume":"435","author":[{"given":"Praveen Kumar","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-7408","authenticated-orcid":false,"given":"Laxit K.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvin K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-5318","authenticated-orcid":false,"given":"Satyam","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpesh Z.","family":"Patani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1286-3559","authenticated-orcid":false,"given":"Shekhar B.","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramchandra K.","family":"Ranvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmikant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harilal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Nyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul R.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cbi.2026.112135_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.cbi.2026.112135_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114616","article-title":"Potentials of peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\/\u03b4, and \u03b3: an in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases","volume":"155","author":"Singh","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cbi.2026.112135_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review","volume":"13","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.cbi.2026.112135_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphar.2020.00730","article-title":"Peroxisome proliferator-activated receptors: experimental targeting for the treatment of inflammatory bowel diseases","volume":"11","author":"Decara","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cbi.2026.112135_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/ATVBAHA.108.179689","article-title":"Fibrates, glitazones, and peroxisome proliferator-activated receptors","volume":"30","author":"Lalloyer","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib6","doi-asserted-by":"crossref","first-page":"bqae154","DOI":"10.1210\/endocr\/bqae154","article-title":"Structural insights into thyroid hormone receptors","volume":"166","author":"Tambones","year":"2024","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cbi.2026.112135_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2026.112135_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.606931","article-title":"Thyroid hormone plays an important role in cardiac function: from bench to bedside","volume":"12","author":"Yamakawa","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2026.112135_bib9","series-title":"Endotext. Mdtext","article-title":"Thyroid hormones in brain development and function","author":"Bernal","year":"2000"},{"issue":"25","key":"10.1016\/j.cbi.2026.112135_bib10","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1073\/pnas.92.25.11593","article-title":"Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways","volume":"92","author":"Chu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.cbi.2026.112135_bib11","doi-asserted-by":"crossref","first-page":"E1380","DOI":"10.1152\/ajpendo.90700.2008","article-title":"PPARalpha activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism","volume":"295","author":"Holness","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1742-7843.2007.00113.x","article-title":"Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice","volume":"101","author":"Jatwa","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/JME-09-0107","article-title":"Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors","volume":"44","author":"Lu","year":"2010","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2009.11.004","article-title":"Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation","volume":"21","author":"Liu","year":"2010","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.136","article-title":"Saroglitazar, a novel PPAR\u03b1\/\u03b3 agonist with predominant PPAR\u03b1 activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models","volume":"3","author":"Jain","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"7","key":"10.1016\/j.cbi.2026.112135_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269531","article-title":"Efficacy and safety of saroglitazar for the management of dyslipidemia: a systematic review and meta-analysis of interventional studies","volume":"17","author":"Chhabra","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib17","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1038\/s41598-020-66458-z","article-title":"The PPAR \u03b1\/\u03b3 agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-019-0884-3","article-title":"New dual peroxisome proliferator activated receptor agonist\u2014Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence","volume":"18","author":"Kaul","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.cbi.2026.112135_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/14656566.2015.1009894","article-title":"Saroglitazar for the treatment of dyslipidemia in diabetic patients","volume":"16","author":"Joshi","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jceh.2021.03.012","article-title":"Safety and efficacy of saroglitazar in nonalcoholic fatty liver patients with diabetic Dyslipidemia-A prospective, interventional, pilot study","volume":"12","author":"Rajesh","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.cbi.2026.112135_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.746924","article-title":"Sex dimorphic responses of the hypothalamus-pituitary-thyroid axis to energy demands and stress","volume":"12","author":"Parra-Montes de Oca","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112135_bib22","series-title":"COMPENDIUM OF CPCSEA 2018","year":"2018"},{"issue":"11","key":"10.1016\/j.cbi.2026.112135_bib23","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/0008-5472.CAN-04-0322","article-title":"Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor \u03b1","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cbi.2026.112135_bib24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgi329","article-title":"Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor \u03b1 to Wy-14,643-induced liver tumorigenesis","volume":"27","author":"Morimura","year":"2006","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/toxsci\/kfm206","article-title":"The ppar\u03b1-humanized mouse: a model to investigate species differences in liver toxicity mediated by ppar\u03b1","volume":"101","author":"Yang","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.cbi.2026.112135_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib27","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/JME-17-0319","article-title":"Effects of thyroid hormones on thermogenesis and energy partitioning","volume":"60","author":"Iwen","year":"2018","journal-title":"J. Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.cbi.2026.112135_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.cbi.2026.112135_bib29","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/ijms20174274","article-title":"Molecular functionality of cytochrome P450 4 (CYP4) genetic polymorphisms and their clinical implications","volume":"20","author":"Jarrar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib30","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-024-48471-2","article-title":"Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cbi.2026.112135_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40618-020-01208-6","article-title":"The interplay between thyroid and liver: implications for clinical practice","volume":"43","author":"Piantanida","year":"2020","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/dmd.107.018184","article-title":"Hepatic UDP-Glucuronosyltransferases responsible for glucuronidation of thyroxine in humans","volume":"36","author":"Kato","year":"2008","journal-title":"Drug Metabol. Dispos.: Biologi. Chem."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2026.112135_bib33","first-page":"10","article-title":"Pathways of thyroid hormone metabolism","volume":"23","author":"Visser","year":"1996","journal-title":"Acta Med. Austriaca"},{"key":"10.1016\/j.cbi.2026.112135_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2017.01.025","article-title":"The classic pathways of thyroid hormone metabolism","volume":"458","author":"van der Spek","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/j.cbi.2026.112135_bib35","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1124\/dmd.107.016097","article-title":"Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes","volume":"35","author":"Yamanaka","year":"2007","journal-title":"Drug Metabol. Dispos.: Biologi. Chem."},{"issue":"8","key":"10.1016\/j.cbi.2026.112135_bib36","first-page":"2879","article-title":"Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man","volume":"85","author":"Findlay","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cbi.2026.112135_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"2","key":"10.1016\/j.cbi.2026.112135_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/toxsci\/kfq125","article-title":"Role of UDP-glucuronosyltransferase (UGT) 2B2 in metabolism of triiodothyronine: effect of microsomal enzyme inducers in sprague dawley and UGT2B2-deficient Fischer 344 rats","volume":"116","author":"Richardson","year":"2010","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.31.3.326","article-title":"Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family","volume":"31","author":"Shelby","year":"2003","journal-title":"Drug Metabol. Dispos.: Biologi. Chem."},{"issue":"10","key":"10.1016\/j.cbi.2026.112135_bib40","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1124\/dmd.106.010397","article-title":"Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways","volume":"34","author":"Shelby","year":"2006","journal-title":"Drug Metabol. Dispos.: Biologi. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112135_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/00498254.2017.1304593","article-title":"The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3)","volume":"48","author":"Chen","year":"2018","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"issue":"6","key":"10.1016\/j.cbi.2026.112135_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/jpm11060554","article-title":"The functionality of UDP-glucuronosyltransferase genetic variants and their Association with drug responses and human diseases","volume":"11","author":"Jarrar","year":"2021","journal-title":"J. Personalized Med."},{"issue":"5","key":"10.1016\/j.cbi.2026.112135_bib43","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3803\/EnM.2021.1198","article-title":"Deiodinases and the three types of thyroid hormone deiodination reactions","volume":"36","author":"Sabatino","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.cbi.2026.112135_bib44","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2002-022013","article-title":"Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients","volume":"88","author":"Peeters","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-004-9011-5","article-title":"Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes","volume":"22","author":"Prueksaritanont","year":"2005","journal-title":"Pharm. Res."},{"issue":"19","key":"10.1016\/j.cbi.2026.112135_bib46","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cbi.2026.112135_bib47","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator\u2013activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cbi.2026.112135_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1023234429596","article-title":"Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices","volume":"20","author":"Martin","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cbi.2026.112135_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.toxrep.2020.12.019","article-title":"Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues","volume":"8","author":"Plummer","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1932296813518680","article-title":"A Multicenter, prospective, randomized, Double-blind study to evaluate the safety and efficacy of saroglitazar 2 and 4 mg compared to pioglitazone 45 mg in diabetic dyslipidemia (PRESS V)","volume":"8","author":"Pai","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112135_bib51","doi-asserted-by":"crossref","first-page":"bnz008","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JME-09-0042","article-title":"Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters","volume":"44","author":"van der Deure","year":"2010","journal-title":"J. Mol. Endocrinol."},{"issue":"16","key":"10.1016\/j.cbi.2026.112135_bib53","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1074\/jbc.M300749200","article-title":"The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene","volume":"278","author":"Barbier","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metabol. Dispos.: Biologi. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2026.112135_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/019262339702500109","article-title":"Mechanistic data and risk assessment of selected toxic end points of the thyroid gland","volume":"25","author":"Capen","year":"1997","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.cbi.2026.112135_bib56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0192623311406934","article-title":"Characterization of xenobiotic-induced hepatocellular enzyme induction in rats: anticipated thyroid effects and unique pituitary gland findings","volume":"39","author":"Zabka","year":"2011","journal-title":"Toxicol. Pathol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:34:29Z","timestamp":1782376469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S0009279726002437"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112135","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saroglitazar, a novel PPAR-\u03b1\/\u03b3 agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112135"}}